| Literature DB >> 27559467 |
Kristine Kjer Byberg1, Geir Egil Eide2, Michele R Forman3, Pétur Benedikt Júlíusson4, Knut Øymar5.
Abstract
BACKGROUND: The results of studies on the associations of childhood excessive weight/obesity and physical activity with atopic sensitization and atopic diseases are inconsistent. We studied the associations of anthropometry and physical activity in childhood with atopic sensitization and atopic diseases in late childhood.Entities:
Keywords: Allergic rhinitis; Anthropometry; Asthma; Atopic dermatitis; Child
Year: 2016 PMID: 27559467 PMCID: PMC4995660 DOI: 10.1186/s13601-016-0124-9
Source DB: PubMed Journal: Clin Transl Allergy ISSN: 2045-7022 Impact factor: 5.871
Fig. 1Percent of children with sensitization (specific IgE > 0.35 kU/l) to common allergens, measured at 12.8 years (n = 388). D: dermatophagoides, C: cladosporium
Descriptive statistics for predictors and outcomes for 617a children included in a matched cohort study with follow-up from birth to 12–13 years in the Stavanger area, Norway
| Predictors | n | Mean | SD |
|---|---|---|---|
| Birthweight (kg) | 606 | 3.37 | 0.71 |
| BMI 3 months | 541 | 16.4 | 1.52 |
| BMI 6 months | 559 | 17.2 | 1.53 |
| BMI 1 year | 559 | 17.2 | 1.49 |
| BMI 4 years | 477 | 15.9 | 1.43 |
| BMI first follow-upb | 610 | 18.0 | 2.91 |
| BMI second follow-upc | 466 | 18.8 | 3.00 |
| Waist circumference (cm) first follow-up | 610 | 63.5 | 7.80 |
| Waist circumference (cm) second follow-up | 466 | 68.0 | 7.72 |
| Triceps skinfold (mm) first follow-up | 605 | 11.7 | 4.63 |
| Triceps skinfold (mm) second follow-up | 465 | 12.1 | 4.81 |
| Waist-to-height ratio first follow-up | 610 | 0.42 | 0.04 |
| Waist-to-height ratio second follow-up | 466 | 0.43 | 0.05 |
| Subscapular skinfold (mm) second follow-up | 450 | 8.21 | 3.24 |
SD standard deviation, BMI body mass index (kg/m2)
aDue to missing values and variation in response, the number of participants varied between the different predictors and outcomes
bFirst follow-up: 10.8 years (girls), 11.8 years (boys)
cSecond follow-up: 12.8 years
d99 (25.5 %) had high grade atopic sensitization (sum of specific IgE ≥ 3.9 kU/l)
The adjusted odds ratios of atopic sensitization and atopic disease in adolescence in 617 Norwegian children by weight/BMI SDS and physical activity after backward stepwise selection of potential confounders (one model for each predictor variable)
| Predictor | Outcome variable (final analyses) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atopic sensitizationa,b | Allergic rhinoconjunctivitisa | Atopic dermatitisc | ||||||||||
| Age | n | OR | 95 % CI | LR-p | n | OR | 95 % CI | LR-p | n | OR | 95 % CI | LR-p |
|
| ||||||||||||
| Birth | 380 | 1.05 | (0.87, 1.26) | 0.609 | 580 | 0.92 | (0.77, 1.10) | 0.338 | 544 | 1.04 | (0.88, 1.22) | 0.638 |
|
| ||||||||||||
| 3 months | 353 | 1.13 | (0.90, 1.41) | 0.315 | 521 | 0.91 | (0.73, 1.14) | 0.427 | 487 | 1.04 | (0.84, 1.30) | 0.694 |
| 6 months | 363 | 1.15 | (0.93, 1.42) | 0.205 | 537 | 0.91 | (0.74, 1.12) | 0.390 | 503 | 1.05 | (0.86, 1.28) | 0.654 |
| 1 year | 363 |
|
|
| 537 | 0.97 | (0.80, 1.18) | 0.795 | 503 | 1.06 | (0.87, 1.28) | 0.557 |
| 4 yearsd | 320 | 1.01 | (0.80, 1.27) | 0.934 | 456 | 0.86 | (0.69, 1.08) | 0.191 | 427 |
|
|
|
| First follow-upe | 358 | 0.95 | (0.79, 1.15) | 0.612 | 562 | 0.87 | (0.73, 1.04) | 0.126 | 527 | 1.11 | (0.93, 1.33) | 0.225 |
| Second follow-upe | 354 | 0.96 | (0.79, 1.17) | 0.680 | N.A. | N.A. | ||||||
|
| ||||||||||||
| At 3–6 yearsf | 320 |
| 456 | 0.157 | 427 | 0.519 | ||||||
| Normal | 192 | 1.00 | Reference | 277 | 1.00 | Reference | 259 | 1.00 | Reference | |||
| Low | 40 |
|
| 57 | 1.60 | (0.83, 3.09) | 57 | 1.30 | (0.65, 2.61) | |||
| High | 88 | 0.90 | (0.50, 1.61) | 122 | 0.77 | (0.44, 1.35) | 111 | 1.34 | (0.78, 2.30) | |||
| At 6–10 yearsg | 358 | 0.773 | 562 | 0.126 | 527 |
| ||||||
| Normal | 234 | 1.00 | Reference | 353 | 1.00 | Reference | 333 | 1.00 | Reference | |||
| Low | 57 | 1.05 | (0.57, 1.96) | 93 | 1.67 | (0.97, 2.87) | 89 | 1.49 | (0.87, 2.56) | |||
| High | 67 | 0.82 | (0.45, 1.49) | 116 | 1.15 | (0.68, 1.93) | 105 |
|
| |||
First follow-up: 10.8 years (girls) and 11.8 years (boys); Second follow-up: 12.8 years (both sexes)
Italics numbers indicate statistically significant results
n number of participants, OR odds ratio, CI confidence interval, LR-p (likelihood ratio-test p-value) refers to predictor only, BMI body mass index (kg/m2), SDS standard deviation score, N.A. not applicable
aAdjusted for sex, preeclampsia and gestational age
bn = 388. Ordinal response: none, low grade, high grade (sum of specific IgE ≥ 3.9 kU/l; above the lower quartile of all children being sensitized)
cAdjusted for sex, mother’s asthma and mother’s smoking
dAlso adjusted for physical activity at 3–6 years
eAlso adjusted for physical activity at 6–10 years
fAlso adjusted for BMI SDS at 4 years
gAlso adjusted for BMI SDS at the first follow-up
The adjusted odds ratios of atopic sensitization and atopic disease in adolescence in 617 Norwegian children by changes in weight/BMI SDS after backward stepwise selection of potential confounders (one model for each predictor variable)
| Predictor | Outcome variable (final analyses) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atopic sensitizationa,b | Allergic rhinoconjunctivitisa | Atopic dermatitisc | ||||||||||
| Age | n | OR | 95 % CI | LR-p | n | OR | 95 % CI | LR-p | n | OR | 95 % CI | LR-p |
|
| ||||||||||||
| Birth to 3 months | 361 | 1.10 | (0.87, 1.38) | 0.408 | 534 | 0.90 | (0.74, 1.09) | 0.292 | 500 | 0.98 | (0.80, 1.17) | 0.835 |
|
| ||||||||||||
| 3–6 months | 351 | 1.15 | (0.83, 1.60) | 0.413 | 519 | 0.96 | (0.71, 1.30) | 0.794 | 485 | 1.15 | (0.85, 1.56) | 0.363 |
| 6 months to 1 year | 360 | 1.30 | (0.95, 1.76) | 0.100 | 534 | 1.11 | (0.83, 1.48) | 0.470 | 500 | 1.07 | (0.81, 1.42) | 0.638 |
| 1–4 years | 325 | 0.82 | (0.62, 1.09) | 0.173 | 456 | 0.82 | (0.63, 1.07) | 0.150 | 427 |
|
|
|
| 4 years to first follow-upd | 315 | 0.99 | (0.78, 1.26) | 0.940 | 450 | 1.01 | (0.80, 1.28) | 0.917 | 422 | 0.87 | (0.70, 1.09) | 0.223 |
| First to second follow-upe | 349 | 0.96 | (0.65, 1.43) | 0.843 | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A |
First follow-up: 10.8 years (girls) and 11.8 years (boys); Second follow-up: 12.8 years (both sexes)
Italics numbers indicate statistically significant results
n number of participants, OR odds ratio, CI confidence interval, LR-p likelihood ratio-test p-value refers to predictor only, BMI body mass index (kg/m2), SDS standard deviation score, N.A. not applicable
aAdjusted for sex, weight/BMI SDS at start of interval, gestational age, preeclampsia (none/mild or moderate/severe)
bn = 388. Ordinal response: none, low grade, high grade (sum of specific IgE ≥ 3.9 kU/l; above the lower quartile of all children being sensitized)
cAdjusted for sex, weight/BMI SDS at start of interval, mother’s asthma and mother’s smoking
dAlso adjusted for physical activity at 3–6 years
eAlso adjusted for physical activity at 6–10 years
The adjusted odds ratios of asthma in adolescence in 617 Norwegian children by weight/BMI SDS and physical activity after backward stepwise selection of potential confounders (one model for each predictor variable)
| Predictor | Outcome variable (final analyses) | |||||||
|---|---|---|---|---|---|---|---|---|
| Asthma ever by first follow-upa | Current asthma at second follow-upb | |||||||
| Age | n | OR | 95 % CI | LR-p | n | OR | 95 % CI | LR-p |
|
| ||||||||
| Birth | 580 | 0.93 | (0.72, 1.20) | 0.587 | 439 | 0.95 | (0.71, 1.27) | 0.716 |
|
| ||||||||
| 3 months | 520 | 0.88 | (0.64, 1.21) | 0.437 | 411 | 0.96 | (0.67, 1.38) | 0.835 |
| 6 months | 536 | 1.06 | (0.79, 1.41) | 0.707 | 425 | 0.86 | (0.61, 1.20) | 0.370 |
| 1 year | 536 | 1.00 | (0.76, 1.32) | 0.998 | 424 | 0.78 | (0.57, 1.08) | 0.127 |
| 4 yearsc | 454 | 1.09 | (0.80, 1.47) | 0.596 | 361 | 0.91 | (0.63, 1.32) | 0.627 |
| First follow-upd | 558 | 1.02 | (0.79, 1.33) | 0.849 | 426 | 1.10 | (0.81, 1.49) | 0.561 |
| Second follow-upd | N.A. | N.A. | N.A. | N.A. | 421 | 1.25 | (0.90, 1.72) | 0.176 |
|
| ||||||||
| At 3–6 yearse | 454 |
| 361 | 0.475 | ||||
| Normal | 275 | 1.00 | Reference | 220 | 1.00 | Reference | ||
| Low | 57 |
|
| 48 | 1.92 | (0.66, 5.59) | ||
| High | 122 | 1.34 | (0.61, 2.97) | 93 | 1.40 | (0.55, 3.55) | ||
| At 6–10 yearsf | 558 |
| 426 | 0.177 | ||||
| Normal | 351 | 1.00 | Reference | 274 | 1.00 | Reference | ||
| Low | 92 |
|
| 69 | 1.98 | (0.80, 4.85) | ||
| High | 115 | 1.02 | (0.46, 2.28) | 83 | 1.97 | (0.83, 4.67) | ||
First follow-up: 10.8 years (girls) and 11.8 years (boys); Second follow-up: 12.8 years (both sexes)
Italics numbers indicate statistically significant results
n number of participants, OR Odds ratio, CI confidence interval, LR-p likelihood ratio-test p-value refers to predictor only, BMI body mass index (kg/m2), SDS standard deviation score, N.A. not applicable
aAfter stepwise backward selection, adjusted for sex, gestational age, mother’s preeclampsia and asthma
bAfter stepwise backward selection, adjusted for sex, mother’s preeclampsia and mother’s asthma
cAlso adjusted for physical activity at 3–6 years
dAlso adjusted for physical activity at 6–10 years
eAlso adjusted for BMI SDS at 4 years
fAlso adjusted for BMISDS at the first follow-up